Renalytix PLCNASDAQ:RNLX
- LAST PRICE2.6300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.5400/ 1
- Ask / Lots2.7000/ 1
- Open / Previous Close0.0000 / 2.6300
- Day Range---
- 52 Week Range
- Volume6,025
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | RNLX |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Renalytix PLC | 93.2M | -1.9x | --- |
Movano Inc | 92.4M | -4.0x | --- |
Innerscope Hearing Technologies Inc | 87.0M | -0.2x | --- |
Optimus Healthcare Services Inc | 77.9M | -470.6x | --- |
Bionoid Pharma Inc | 111.0M | 1.8x | --- |
Pulse Biosciences Inc | 59.0M | -0.7x | --- |
Company Information
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company. The Company is focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. The Company's diagnostic platform, KidneyIntelX, is designed to scale across kidney disease conditions beyond diabetic kidney disease. The Company is evaluating a range of new indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and coronavirus disease (COVID)-related kidney disease. KidneyIntelX platform facilitates the identification and promotes the effective management of patients at risk of early-stage diabetic kidney disease (DKD), progression by combining diverse data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record (HER) using a proprietary algorithm to generate a unique patient risk score.
Contact Information
- Headquarters
- Avon Hse, 19 Stanwell RoadPENARTH, United Kingdom CF64 2EZ
- Phone
- 207-933-8780
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $93.2M |
|---|---|
Revenue (TTM) | $2.6M |
Shares Outstanding | 37.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.38 |
Book Value | $1.98 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 35.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,903.75% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
